The global prefilled syringes market share is projected to grow from US$ 6.69 Billion in 2022 to US$ 15.0 Billion by 2030, ...
Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...
Despite consistent improvements in glycemic outcomes across simulations, real-world adoption is lagging. The study finds that ...
Research suggests that automated insulin delivery (AID) systems may play a significant role in enhancing glucose management.
Beta Bionics recently brought its iLet bionic pancreas to market in 2023 and completed an IPO to become a publicly-traded ...
A Pittsburgh firm is harnessing artificial intelligence to make it easier for military aircraft to land on ships at sea.
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the effects of a regimen of inhaled technosphere insulin (TI) and insulin degludec over 30 weeks and its ...
Vicentra BV aims to make its Kaleido 2 insulin patch pump and automated insulin delivery system even smaller than its current device, already amongst the smallest, lightest and most precise insulin ...
A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...
Clinical Trials Arena on MSN8d
Omnipod 5 improves glycaemic levels in people transitioning from daily injectionsIndividuals transitioning from multiple daily injections to the Omnipod 5 system experienced an average HbA1c reduction of ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback